Complete Deficiency of the Low-Density Lipoprotein Receptor Is Associated With Increased Apolipoprotein B-100 Production

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2005-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.ATV.0000155323.18856.a2PMID 15637307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study.

  2004cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00)

  2004cited by this paper
• Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation Published, JLR Papers in Press, February 16, 2004. DOI 10.1194/jlr.M300448-JLR200

  2004cited by this paper
• Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.

  2003cited by this paper
• WinSAAM: a windows-based compartmental modeling system.

  2003cited by this paper
• Normal Production Rate of Apolipoprotein B in LDL Receptor–Deficient Mice

  2002cited by this paper
• The role of the LDL receptor in apolipoprotein B secretion.

  2000cited by this paper
• Low‐density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia

  2000cited by this paper
• Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry.

  2000cited by this paper
• Influence of b-Thalassemia on the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia A Study of Patients With Familial Hypercholesterolemia From Sardinia

  1999cited by this paper
• A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males.

  1999cited by this paper
• Clinically applicable mutation screening in familial hypercholesterolemia

  1996cited by this paper
• Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom.

  1996cited by this paper
• Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing.

  1995cited by this paper
• Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.

  1995cited by this paper
• Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.

  1994cited by this paper
• Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

  1993cited by this paper
• Molecular genetics of the LDL receptor gene in familial hypercholesterolemia

  1992cited by this paper
• The unstirred water layer as a site of control of apolipoprotein B secretion.

  1990cited by this paper
• An efficient salt-chloroform extraction of DNA from blood and tissues.

  1989cited by this paper
• Apolipoprotein B metabolism in homozygous familial hypercholesterolemia.

  1989cited by this paper
• Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.

  1989cited by this paper
• The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum.

  1987cited by this paper
• A rapid micromethod for apolipoprotein E phenotyping directly in serum.

  1987cited by this paper
• Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit.

  1986cited by this paper
• Effects of 1,2-cyclohexanedione modification on the metabolism of very low density lipoprotein apolipoprotein B: potential role of receptors in intermediate density lipoprotein catabolism.

  1985cited by this paper
• Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits.

  1983cited by this paper
• The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia.

  1982cited by this paper
• Decreased cholesterol and fatty acid synthesis following portacaval shunt.

  1977cited by this paper
• Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol.

  1973cited by this paper

• Toward an Integrated Therapeutic Approach for Familial Hypercholesterolemia

  2026cites this paper
• Advances in familial hypercholesterolemia.

  2024cites this paper
• The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestor.

  2024cites this paper
• Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

  2022cites this paper
• Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

  2022cites this paper
• Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding

  2022cites this paper
• New algorithms for treating homozygous familial hypercholesterolemia

  2022cites this paper
• Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the Week.

  2022cites this paper
• ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report

  2021cites this paper
• On the possible existence of a liver LDL-ostat, and its malfunctioning in familial hypercholesterolemia.

  2021cites this paper
• The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer

  2021cites this paper
• Unravelling Lipoprotein Metabolism with Stable Isotopes: Tracing the Flow.

  2021cites this paper
• Triglycerides and cardiovascular disease

  2021cites this paper
• Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression

  2021cites this paper
• Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.

  2020cites this paper
• Zebrafish as an Emerging Model for Dyslipidemia and Associated Diseases

  2020cites this paper
• Plasma proteome profiling of freshwater and seawater life stages of rainbow trout (Oncorhynchus mykiss)

  2020cites this paper
• Causes and Consequences of Hypertriglyceridemia

  2020cites this paper
• Delayed postprandial TAG peak after intake of SFA compared with PUFA in subjects with and without familial hypercholesterolaemia: a randomised controlled trial

  2018cites this paper
• High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.

  2018cites this paper
• Delayed postprandial TAG peak after intake of SFA compared with PUFA in subjects with and without familial hypercholesterolaemia: a randomised controlled trial

  2018cites this paper
• Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice

  2018cites this paper
• Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans

  2016cites this paper
• ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia.

  2016cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward.

  2016cites this paper
• Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.

  2016cites this paper
• Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

  2016cites this paper
• The Role of Microsomal Triglyceride Transfer Protein Inhibitors in the Treatment of Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management

  2015cites this paper
• Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

  2015cites this paper
• Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia.

  2015cites this paper
• Apolipoprotein-B: The Crucial Protein of Atherogenic Lipoproteins

  2015cites this paper
• From Human-Induced Pluripotent Stem Cells to Liver Disease Modeling: A Focus on Dyslipidemia

  2015cites this paper
• Lipoprotein metabolism in familial hypercholesterolemia: Serial assessment using a one-step ultracentrifugation method

  2015cites this paper
• Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.

  2014cites this paper
• Microsomal transfer protein (MTP) inhibition—a novel approach to the treatment of homozygous hypercholesterolemia

  2014cites this paper
• Practical immunoaffinity-enrichment LC-MS for measuring protein kinetics of low-abundance proteins.

  2014cites this paper
• Changes in lipoprotein kinetics associated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins.

  2014cites this paper
• The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies.

  2014cites this paper
• Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin.

  2013cites this paper
• The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.

  2013cites this paper
• Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry.

  2013cites this paper
• Altered Metabolism of Low-Density Lipoprotein and Very-Low-Density Lipoprotein Remnant in Autosomal Recessive Hypercholesterolemia: Results From Stable Isotope Kinetic Study In Vivo

  2012cites this paper
• Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia

  2012cites this paper
• Measurement of fractional synthetic rates of multiple protein analytes by triple quadrupole mass spectrometry.

  2012cites this paper
• Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box.

  2012cites this paper
• Retinol-Binding Protein 4 Is an Independent Factor Associated With Triglycerides and a Determinant of Very Low-Density Lipoprotein–Apolipoprotein B100 Catabolism in Type 2 Diabetes Mellitus

  2012cites this paper
• The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions.

  2012cites this paper
• JD induced pluripotent stem cell–derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia

  2012cites this paper
• Familial genetic risk factors in premature cardiovascular disease: a family study

  2012cites this paper
• Supplemental Material II

  2012cites this paper
• Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.

  2011cites this paper
• The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarction.

  2011cites this paper
• Studies on PCSK9 in the regulation of cholesterol metabolism

  2011cites this paper
• Lack of association between plasma PCSK9 and LDL-apoB100 catabolism in patients with uncontrolled type 2 diabetes.

  2011cites this paper
• Gene therapy for familial hypercholesterolemia.

  2011cites this paper
• Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk

  2011cites this paper
• Turkey ! e relationship between lipoprotein ( a ) and coronary artery disease , as well as its variable nature following myocardial infarction

  2011cites this paper
• Familial hypercholesterolemia and triglyceride metabolism.

  2011cites this paper
• Opposing Effects of Apolipoprotein M on Catabolism of Apolipoprotein B–Containing Lipoproteins and Atherosclerosis

  2010cites this paper
• Regulation of plasma LDL: the apoB paradigm

  2009cites this paper
• Overview of the LDL receptor: relevance to cholesterol metabolism and future approaches for the treatment of coronary heart disease

  2009cites this paper
• Insulin Acutely Inhibits Intestinal Lipoprotein Secretion in Humans in Part by Suppressing Plasma Free Fatty Acids

  2009cites this paper
• Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III

  2009cites this paper
• Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.

  2009cites this paper
• Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia.

  2008cites this paper
• Regulation of ApoB Secretion by the Low Density Lipoprotein Receptor Requires Exit from the Endoplasmic Reticulum and Interaction with ApoE or ApoB*

  2008cites this paper
• Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes

  2008cites this paper
• Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality control

  2008cites this paper
• Investigating the Functional Role of Prostate-Specific Membrane Antigen and its Enzymatic Activity in Prostate Cancer Metastasis

  2007cites this paper
• Genetics of familial hypobetalipoproteinemia

  2007cites this paper
• Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.

  2007cites this paper
• Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice.

  2007cites this paper
• The physiological and molecular regulation of lipoprotein assembly and secretion.

  2007cites this paper
• Thematic review series : Patient-Oriented Research What we have learned about VLDL and LDL metabolism from human kinetics studies

  2006cites this paper
• Thematic review series: Patient-Oriented Research. What we have learned about VLDL and LDL metabolism from human kinetics studies Published, JLR Papers in Press, May 23, 2006.

  2006cites this paper
• Concentration of Circulating Oxidized LDL in HIV-Infected Patients Treated with Antiretroviral Agents: Relation to HIV-Related Lipodystrophy

  2006cites this paper
• Effects of the Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib on Apolipoprotein B100 Metabolism in Humans

  2006cites this paper
• New therapies for familial hypercholesterolemia

  2006cites this paper
• Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor.

  2006cites this paper
• Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia

  2006cites this paper
• Percentage Lipid Composition of VLDL , IDL , and LDL Fractions During the Placebo and 120 mg Torcetrapib

  2006cites this paper
• Microarray Analysis Identifies Novel Cholesterol Regulated Genes, Including Pcsk9 Which Regulates LDL Receptor Function and LDL Cholesterol Levels

  2006cites this paper
• Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat Published, JLR Papers in Press, May 9, 2006.

  2006cites this paper
• Low Density Lipoprotein Apolipoprotein B Metabolism in Treatment-Naive HIV Patients and Patients on Antiretroviral Therapy

  2005cites this paper
• Therapy and clinical trials.

  2005cites this paper